Skip to main content
. Author manuscript; available in PMC: 2012 Jan 15.
Published in final edited form as: Drug Alcohol Depend. 2010 Sep 15;113(2-3):192–199. doi: 10.1016/j.drugalcdep.2010.07.025

Figure 3b.

Figure 3b

Differences in log10 viral load by study arm at each assessment point during the 24-week intervention period, stratified by baseline viral load (≥75 copies/ml versus <75 copes/ml). Precise estimates available in online supplementary materials.

DOT: directly observed therapy; TAU: treatment as usual; VL: viral load

*p<0.02 for difference between DOT and TAU among participants with detectable baseline VL, based on mixed effects model analysis.